«Taking a young person’s plasma and infusing it into an older person to ward off aging — a therapy that’s fascinated some of the biggest names in Silicon Valley — has no proven clinical benefit, the Food and Drug Administration said.
….
The idea of infusing young blood to fight aging has attracted technology entrepreneurs like billionaire Peter Thiel and was lampooned in a 2017 episode of the HBO show “Silicon Valley.” Thiel’s reported interest was sparked by a company called Ambrosia, which has locations in five states across the U.S. and sells one liter of blood plasma from donors between the ages of 16 and 25 for $8,000, according to its website.
Ambrosia’s website was updated Tuesday to say it has “ceased patient treatments” in compliance with the FDA’s advisory.»
Infusing Young Blood to Prevent Aging No Proven Benefit, FDA Says – Bloomberg
Leave a reply
Here, Read This 